Literature DB >> 3030413

Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides.

J C Sarup, A Fridland.   

Abstract

Cell extracts from human leukemic T lymphoblasts and myeloblasts were chromatographed on DEAE-cellulose columns to separate purine deoxyribonucleoside, deoxyadenosine (dAdo) and deoxyguanosine (dGuo), phosphorylating activities. Three distinct purine deoxyribonucleoside kinases, a deoxycytidine (dCyd) kinase, an adenosine (Ado) kinase, and a deoxyguanosine (dGuo) kinase (the latter appears to be localized in mitochondria), were resolved. dCyd kinase contained the major phosphorylating activity for dAdo, dGuo, and 9-beta-D-arabinofuranosyladenine (ara-A). Ado kinase represented a second kinase for dAdo and ara-A while a third kinase for dAdo was found in mitochondria. dCyd kinase was purified about 2000-fold with ion-exchange, affinity, and hydrophobic chromatographies. On gel electrophoresis, both dCyd and dAdo phosphorylating activities comigrated, indicating that the activities are associated with the same protein. The enzyme showed a broad pH optimum ranging from pH 6.5 to pH 9.5. Divalent cations Mg2+, Mn2+, and Ca2+ stimulated dCyd kinase activity; Mg2+ produced the maximal activity. dCyd kinase from either lymphoid or myeloid cells showed broad substrate specificity. The enzyme used several nucleoside triphosphates, but ATP, GTP, and dTTP were the best phosphate donors. dCyd was the best nucleoside substrate, since dCyd kinase had an apparent Km of 0.3, 85, 90, and 1400 microM for dCyd, dAdo, dGuo, and ara-A, respectively. The enzyme exhibited substrate activation with both pyrimidine and purine deoxyribonucleosides, suggesting that there is more than one substrate binding site on the kinase. These studies show that, in lymphoblasts and myeloblasts, purine deoxyribonucleosides and their analogues are phosphorylated by dCyd kinase, Ado kinase, and dGuo kinase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030413     DOI: 10.1021/bi00376a034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Direct photoaffinity-labelling of human deoxycytidine kinase with the feedback inhibitor dCTP.

Authors:  O Jansson; S Eriksson
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

2.  Cellular delivery of nucleoside diphosphates: a prodrug approach.

Authors:  S H Kang; A K Sinhababu; J G Cory; B S Mitchell; D R Thakker; M J Cho
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

3.  Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis.

Authors:  Maria Angulo-Ibáñez; Xavier Rovira-Clavé; Alba Granados-Jaén; Bradley Downs; Yeong C Kim; San Ming Wang; Manuel Reina; Enric Espel
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Characterization of the deoxycytidine kinase promoter in human lymphoblast cell lines.

Authors:  E H Chen; E E Johnson; S M Vetter; B S Mitchell
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

5.  Human thymidine kinase can functionally replace herpes simplex virus type 1 thymidine kinase for viral replication in mouse sensory ganglia and reactivation from latency upon explant.

Authors:  S H Chen; W J Cook; K L Grove; D M Coen
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

6.  Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues.

Authors:  Theresa McSorley; Stephan Ort; Saugata Hazra; Arnon Lavie; Manfred Konrad
Journal:  FEBS Lett       Date:  2008-02-05       Impact factor: 4.124

7.  Cloning and expression of human deoxycytidine kinase cDNA.

Authors:  E G Chottiner; D S Shewach; N S Datta; E Ashcraft; D Gribbin; D Ginsburg; I H Fox; B S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 8.  Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases.

Authors:  An R Van Rompay; Magnus Johansson; Anna Karlsson
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.